INDIAN PHARMA NEWS: Pioglitazone seen as bitter pill by patients, - TopicsExpress



          

INDIAN PHARMA NEWS: Pioglitazone seen as bitter pill by patients, diabetologists & pharma cos who await its suspension to be revoked: Pioglitazone is now seen to be the bitter pill for not just diabetics but diabetologists and pharma companies who are at the receiving end as they expect that the suspended drug will now be back in the market. Currently, pioglitazone is under scrutiny by the Drug Technical Advisory Board (DTAB) which will come out with its final decision on July 19.
Posted on: Sun, 21 Jul 2013 16:36:39 +0000

Trending Topics



Recently Viewed Topics




© 2015